Nuyen Brenda, Mansouri Kaweh
Hamilton Glaucoma Center and Department of Ophthalmology, University of California, San Diego, La Jolla, California, USA.
Glaucoma Center, Montchoisi Clinic, Genolier Swiss Vision Network, Lausanne, Switzerland; Department of Ophthalmology, University of Colorado School of Medicine, Aurora, Colorado, USA.
Open Ophthalmol J. 2016 Feb 29;10:44-55. doi: 10.2174/1874364101610010044. eCollection 2016.
Lowering intraocular pressure (IOP) remains the guiding principle of glaucoma management. Although IOP is the only treatable risk factor, its 24-hour behavior is poorly understood. Current glaucoma management usually relies on single IOP measurements during clinic hours, even though IOP is a dynamic parameter with rhythms dependent on individual patients. It has further been shown that most glaucoma patients have their highest IOP measurements outside clinic hours. The fact that these IOP peaks go largely undetected may explain why certain patients progress in their disease despite treatment. Nevertheless, single IOP measurements have determined all major clinical guidelines regarding glaucoma treatment. Other potentially informative parameters, such as fluctuations in IOP and peak IOP, have been neglected, and effects of IOP-lowering interventions on such measures are largely unknown. Continuous 24-hour IOP monitoring has been an interest for more than 50 years, but only recent technological advances have provided clinicians with a device for such an endeavor. This review discusses current uses and shortcomings of current measurement techniques, and provides an overview on current and future methods for 24-hour IOP assessment. It may be possible to incorporate continuous IOP monitoring into clinical practice, potentially to reduce glaucoma-related vision loss.
降低眼压仍然是青光眼治疗的指导原则。尽管眼压是唯一可治疗的危险因素,但其24小时变化规律却鲜为人知。目前的青光眼治疗通常依赖于门诊时间的单次眼压测量,然而眼压是一个动态参数,其节律因个体患者而异。进一步的研究表明,大多数青光眼患者在门诊时间之外眼压测量值最高。这些眼压峰值大多未被检测到,这或许可以解释为什么某些患者尽管接受了治疗,病情仍在进展。尽管如此,单次眼压测量决定了所有关于青光眼治疗的主要临床指南。其他可能提供信息的参数,如眼压波动和眼压峰值,一直被忽视,而且降低眼压干预措施对这些指标的影响也大多未知。持续24小时眼压监测已经受到关注超过50年,但直到最近的技术进步才为临床医生提供了进行此类监测的设备。本文综述了当前测量技术的应用和不足,并概述了当前及未来24小时眼压评估的方法。将持续眼压监测纳入临床实践或许是可行的,这有可能减少与青光眼相关的视力丧失。